aTyr Pharma to Present at the 2023 RBC Capital Markets Global Healthcare Conference
May 11 2023 - 4:00PM
aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged
in the discovery and development of first-in-class medicines from
its proprietary tRNA synthetase platform, today announced that
Sanjay S. Shukla, M.D., M.S., President and Chief Executive
Officer, will present at the 2023 RBC Capital Markets Global
Healthcare Conference, which is scheduled to take place May 16 –
17, 2023, in New York, NY.
Details of the presentation appear below:
Conference: 2023 RBC Capital Markets Global Healthcare
ConferenceDate: Tuesday, May 16, 2023 Time: 10:30am EDTLocation:
New York, NYFormat: Fireside Chat
In addition to the presentation, company
management will be available to participate in one-on-one meetings
with investors who are registered attendees of the conference. An
audio webcast of the event will be available on the Investor’s
section of the company’s website at www.atyrpharma.com. Following
the event, a replay of the presentation will be available on the
aTyr website for at least 90 days.
About aTyr
aTyr is a biotherapeutics company engaged in the
discovery and development of first-in-class medicines from its
proprietary tRNA synthetase platform. aTyr’s research and
development efforts are concentrated on a newly discovered area of
biology, the extracellular functionality and signaling pathways of
tRNA synthetases. aTyr has built a global intellectual property
estate directed to a potential pipeline of protein compositions
derived from 20 tRNA synthetase genes and their extracellular
targets. aTyr’s primary focus is efzofitimod, a clinical-stage
product candidate which binds to the neuropilin-2 receptor and is
designed to downregulate immune engagement in fibrotic lung
disease. For more information, please visit www.atyrpharma.com.
Contact:Ashlee DunstonDirector, Investor
Relations and Corporate Communicationsadunston@atyrpharma.com
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2024 to May 2024
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From May 2023 to May 2024